News & Statements
T1International Advocates Attend State of the Union to advocate for #insulin4all
13 Feb 2020, 8:09 a.m. in #insulin4all USA, News & Statements by Kristen Whitney Daniels & Sarah Stark
Some of the most important advocacy often happens in the shadows – in small meeting rooms, online, in the hours of pouring over legislation and building factsheets and bringing together a community fighting for change. Those efforts, full of blood sweat and tears, are paying off, even if it is not obvious. However, sometimes those efforts result in a chance to represent your community in a significant and public way. We are thrilled that so many advocates impacted by type 1 diabetes were invited to the 2020 State of the Union. Two of those advocates share their perspectives here. Read more
T1International Launches Communities of Color Campaign
10 Feb 2020, 9:47 p.m. in #insulin4all USA, News & Statements by T1International
As the celebration of Black History Month is underway in the United States, T1International is launching its Communities of Color campaign. This campaign aims to highlight the need for better representation and genuine inclusion of people of color (PoC) within the diabetes community and to encourage participation and inclusion of PoC in the #insulin4all movement fighting for access to affordable insulin and diabetes care. Read more
T1International Statement on Brexit
31 Jan 2020, 9:19 a.m. in News & Statements by T1International
We stand ready to hold the UK government to account on the provision of healthcare for UK citizens with type 1 diabetes over the coming months and years. We will strongly resist any erosion of the current provision of essential medicine and supplies, medical devices or support services for patients with type 1 diabetes in the UK. Read more
#insulin4all Demonstration Outside Sanofi in Paris
20 Jan 2020, 1:59 p.m. in Global Stories, News & Statements by Matthieu de Mijolla/ Bertrand Burgalat/ Adrianna Maciejczyk
On the 8th of January, members of Diabète et Méchant, the French Chapter of T1International, demonstrated in front of Sanofi’s headquartered in Paris against their insulin price policy. The demonstration was meant to commemorate the 98th anniversary of the first successful injection of insulin in 1922. Read more
T1International Year in Review: 2019
19 Dec 2019, 10:01 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
We have had a truly incredible year. Unprecedented growth is the only way to put it. The global insulin crisis continues, but the momentum to counter this crisis is growing, thanks to patients around the world standing up and fighting for their right to health. Below, we share a summary of our highlights and biggest achievements, thanks to your donations, your advocacy, and your dedication to ensuring #insulin4all becomes a reality. Read more
Kentuckians Demand Legislation to Address Insulin Costs, Not Pharma-Funded Talking Points
2 Dec 2019, 9:28 a.m. in #insulin4all USA, News & Statements by Angela Lautner and Sarah Ferguson
Anything short of these 3 things mean that there will still be Kentuckians who suffer and possibly die. Money from the “big 3” insulin makers is influencing established advocacy groups across the United States, including some of the testimony heard at the August 21st ommittee meeting. When ideas are proposed that specifically remove blame and accountability from Pharma, it may be a key indicator of who is funding that group. Read more
#insulin4all Workshop & Vigil
25 Oct 2019, 10:09 a.m. in #insulin4all USA, News & Statements by T1International
In September 2019, T1International held our first ever two-day #insulin4all workshop for USA Chapters. The purpose of the workshop was to bring Chapter Leaders together and build their skills and advocating power to push for more affordable, accessible insulin and supplies. About 45 people from about 20 Chapters across the USA came to Indianapolis for the workshop, which included a third annual event outside of Eli Lilly taking the form of a vigil to honor lives lost due to rationing. Read more
Novo Nordisk Meeting: 2 Executives, 2 Doctors, 1 Patient
10 Jul 2019, 10:34 a.m. in #insulin4all USA, News & Statements by Karlynn Holland
Although Lars said that he is “Not shying away from anything that costs money,” it was clear that he was not going to lower the list price. I’m not holding my breath and we, the diabetes community, are not going to wait. Only legislation will ensure insulin is truly accessible and affordable for all. We will not stop until that is the reality because our lives depend on it. Read more
Colorado’s Insulin Copay Cap: A Foundation to Build Upon
9 Jul 2019, 9:13 a.m. in #insulin4all USA, News & Statements by Allison Bailey
With Governor Polis’ declaration that “the days of insulin price gouging are over in Colorado,” news outlets across the country published stories with headlines about the $100 price cap, patients lauded Colorado’s big step forward, and lawmakers from other states voiced interest in following suit. This bill was a victory for Colorado #insulin4all advocates. But with every victory, it is necessary to look beyond the headlines and explore the small print. Read more
T1International Releases Report on Rationing and Cost Survey Data
18 Jun 2019, 8 a.m. in #insulin4all USA, News & Statements by T1International
Results found that dangerous and potentially fatal insulin rationing is widespread globally, with 18.0% of all country respondents having rationed insulin at least once in the previous year. It also found that respondents from the USA paid more by the dollar for insulin than almost any other country and that 25.9% of U.S. respondents reported having rationed insulin in the previous year. This confirms similar findings from previous smaller-scale surveys that one of every four people in the United States have had to ration insulin. Read more